Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(17%)
Results Posted
14%(1 trials)

Phase Distribution

Ph not_applicable
11
92%
Ph early_phase_1
1
8%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Recruiting2
unknown1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (8.3%)
N/A11 (91.7%)

Trials by Status

unknown18%
withdrawn18%
recruiting217%
completed758%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12